All Rights Reserved. Forward ® 2017
EBD Group Inc., 2032 Corte Del Nogal, Ste. 120, 92011 Carlsbad, CA
Join us at the inaugural
Cell & Gene Exchange
May 22–23, 2017 // Washington DC
The event brings together the regulatory, business and patient advocacy communities to enable the development of meaningful partnerships to advance the cell and gene therapy sector.
Biopharma companies are working with patient advocacy foundations sooner—and closer—than ever before. As a result, companies are gaining insights very early in the therapeutic development stage that can streamline and speed scientific advances and regulatory approval.
Read the full article
Biotech Engages Patients Earlier than Ever
Advances in Cell and Gene Therapies Provide New Opportunities
Industry leaders and patient advocacy groups collaborate to advance R&D.
More than 800 clinical trials are underway in the regenerative medicine sector resulting in scientific advances in areas of unmet medical need, especially in rare diseases. Read more about the important role of partnerships in advancing the sector.